Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements
Provided By GlobeNewswire
Last update: Feb 13, 2025
Gross profit increase of 32.6% and 11-point gross profit margin increase driven by higher-margin cartridge sales
Submitted FDA 510(k) and remain on track for planned expansion into multi-billion dollar U.S. market in 2025
Read more at globenewswire.com
